RxDoctor Payments Data

William Nutting, MD

Family Medicine · Aubrey, TXNPI 1902216120

Payments from drug & device makers

$162in general payments, 2019–2025

Across 11 payments — averaging $14.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$29
  • Boehringer Ingelheim$25
  • Merck$24
  • Abbott$23
  • Exact Sciences$21
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$15
  • plus $25 from 2 others

What the payments were for

  • Food & beverage$162100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$162 in reported general payments places this provider in the 30th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$71,546
Medicare patients
145
Services billed
2,442

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$86,924
JardianceEmpagliflozin47$55,043
EliquisApixaban32$46,440
MounjaroTirzepatide39$43,580
TrulicityDulaglutide14$26,054
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$20,450
JanuviaSitagliptin Phosphate22$16,967
MyrbetriqMirabegron12$11,977
Duloxetine Hcl100$2,592
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$2,557
Atorvastatin Calcium322$2,462
SynthroidLevothyroxine Sodium22$2,423
Gabapentin92$1,830
Albuterol Sulfate HfaAlbuterol Sulfate79$1,647
Levothyroxine Sodium193$1,641

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$13$86,92462 claims
Boehringer IngelheimJardiance$25$55,04347 claims
MerckJanuvia$24$16,96722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Aubrey

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →